JD Supra

FDA’s Office of Dietary Supplement Programs Signals Key Enforcement and Policy Priorities for the Year Ahead

During a recent industry webinar, Cara Welch, Ph.D., Director of the Office of Dietary Supplement Programs (“ODSP”) within the U.S. Food and Drug Administration (“FDA”), outlined the agency’s 2026 ...
RAPS

FDA Considers Creating New 'Office of Patient Affairs'

As part of efforts to better capture patients' perspectives, the US Food and Drug Administration (FDA) on Monday said it is considering establishing an "Office of Patient Affairs," to be tasked with ...
JD Supra

JPM 2026: FDA panelists prioritize faster approvals, national security, AI, and more

Speaking at the 2026 J.P. Morgan Healthcare Conference, Hogan Lovells global regulatory partners Elizabeth Jungman and Brian Carey moderated a panel discussion with U.S. Food and Drug Administration ...
Yahoo

US FDA removes longtime director of over-the-counter drugs office

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29 ...
Hosted on MSN

FDA opens door to feedback on 'unclear' national priority voucher pathway

The US Food and Drug Administration (FDA) will convene a public hearing intended to obtain feedback on its Commissioner's National Priority Voucher (CNPV) pilot programme, a framework that has ...
Hosted on MSN

FDA's plan to boost cheaper copycat drugs could stall at patent office

While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
The Spokesman-Review

FDA’s plan to boost biosimilar drugs could stall at the patent office

While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer and other diseases, the U.S. patent office is making it harder for the ...